HUMASIS CO. LTD. Funds and ETFs Humasis Co. Ltd.
Equities
A205470
KR7205470008
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,926 KRW | -0.57% |
|
-0.62% | +2.12% |
| 18/03 | Humasis Co. Ltd. announces an Equity Buyback for 17,533,607 shares. | CI |
| 18/03 | Humasis Co. Ltd. authorizes a Buyback Plan. | CI |
ETFs positioned on Humasis Co. Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Humasis Co Ltd is a Korea-based company principally engaged in the manufacture and sale of in vitro diagnostic devices. The Company is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The Company sells its products within domestic market and to overseas markets. The Company was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.
Calendar
14/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.12% | 18Cr | |
| -3.63% | 1.24TCr | |
| -1.48% | 836.95Cr | |
| +10.09% | 583.76Cr | |
| +25.61% | 539.81Cr | |
| -4.58% | 436.65Cr | |
| -51.80% | 322.85Cr | |
| +16.25% | 279.52Cr | |
| +30.25% | 225.64Cr | |
| -4.08% | 187.43Cr |
- Stock Market
- Equities
- A205470 Stock
- Funds and ETFs Humasis Co. Ltd.